KFDA to support off-label use of medications

Published: 2010-09-09 06:57:00

Updated: 2010-09-09 06:57:00

The Korea Food and Drug Administration plans to provide a variety of incentives to an applicant intends to initiate new clinical trials of off-label drugs to generate additional data for approval agencies to expand indications of proprietary drugs.

Off-label use is the practice of prescribing ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK